Inflammatory Respiratory Diseases: Correlation Between Lung Cancer and COVID-19

Lung cancer has been identified as one of the most prevalent causes of illness and death. Lung cancer is also categorized as among the most prevalent types of cancers, along with breast, colorectal, and prostate cancers. Worldwide attempts to manage diseases have remained steady, and lung cancer is expected to remain the primary cause of cancer-related burdens worldwide. The prevalence of lung cancer cases is expected to rise to 3.2 million by 2040. The unpredictable appearance of the 2019 coronavirus disease (COVID-19) has dramatically changed our real lives. This not only has altered our current perspective on life but has also compelled us to redesign how cancer patients should be diagnosed. New studies have also found that the mortality risk of COVID-19 lung cancer patients is larger than that of other cancer patients and that cancerstage has a strong connection with mortality. Further detailed studies are required to strategize treatment plans and to effectively manage the condition.